News related to
chief

OpenAI’s chief executive Sam Altman delivered a candid message to students at the Indian Institute of Technology Delhi, telling them that conventional career guidance may be of limited value as artificial intelligence reshapes the world of work. Speaking at an interactive session in Dogra Hall, Altman said that younger generations will have to trust their own instincts and adapt to fast-changing technological landscapes rather than relying on established rules or advice from older generations. His remarks underscored a broader debate about how work, education and ambition will evolve alongside accelerating AI developments.

Addressing a packed audience, Altman said that the “biggest mistake young people make” is listening too closely to traditional wisdom on careers passed down by their elders. He acknowledged that even he did not claim to have a firm grasp on the pace of change, urging students to cultivate independent judgment and flexibility instead. “For a predictor of what the world is going to be like going forward, I don’t think you should trust me for having good intuition of the rate of change,” he said, emphasising that those entering the workforce must be prepared to navigate uncertainty and disruption.

Altman’s comments reflected a growing consensus among technology leaders that the job market and the nature of work are undergoing fundamental transformation as generative AI and automation systems become more capable. Traditional professions that once seemed secure are being rethought, while new categories of employment linked to AI development, oversight and ethical deployment are emerging. Altman’s view was echoed elsewhere at global forums where he and other AI leaders have stressed the need for adaptability, lifelong learning and creative problem-solving.

During the session at the institute, Altman clarified that while parents and mentors remain important for personal values, their career advice – rooted in past paradigms – may not offer reliable direction amid rapid technological shifts. He said young people must develop what he called “agency,” a capacity to shape their own paths, learn from failure and recalibrate as conditions evolve. “Young people always figure this out best,” he told the students, highlighting the creative energy he sees in younger cohorts.

Altman also acknowledged that the rise of artificial intelligence will entail changes in employment structures, with some roles becoming obsolete even as new opportunities are created. He stressed that preparing for the future will require calculated risk-taking and an openness to reinventing career plans rather than adhering to criteria like stability and predictability alone. His advice resonated with students grappling with how to position themselves in a world where AI tools are becoming deeply integrated into industries from healthcare to finance.

Reactions to Altman’s remarks have been varied. Some students and observers praised his emphasis on independent thought and adaptability, seeing it as realistic guidance for navigating disruption. Others questioned whether the message might undermine confidence in tried-and-tested pathways into professions such as engineering, medicine and law that have long been valued for stability and societal contribution. This tension illustrates the broader uncertainty about how best to prepare for a future shaped by rapid technological evolution.

Altman’s visit to the institute took place against the backdrop of major international discussions about the role of artificial intelligence in economic and social life. In New Delhi last month, global tech leaders and policymakers gathered for a major AI summit focused on collaboration, governance and responsible innovation. Altman’s remarks at IIT Delhi dovetail with themes emerging from those dialogues, where experts have called for societies to rethink education systems, regulatory frameworks and workforce strategies to accommodate profound shifts driven by AI capabilities.

His message to students also reflects a generational contrast in attitudes towards technology and opportunity. Younger people, he suggested, have an inherent advantage when it comes to understanding and experimenting with emerging tools and platforms. As AI becomes more pervasive, Altman said, those who can integrate machine intelligence with human creativity and judgement will be best positioned to thrive, even as older models of career guidance lose relevance.

Lucid Group expects production growth in 2026 to moderate as it scales up its new Gravity sport utility vehicle and prepares a broader push into the midsize electric vehicle segment, cautioning that supply-chain risks and cost pressures could restrain expansion. The California-based electric vehicle maker has begun increasing output of the Gravity SUV at its plant in Casa Grande, Arizona, positioning the model as a cornerstone of […]

Jada Fund of Funds, a subsidiary of Saudi Arabia’s Public Investment Fund, is preparing to channel more capital into private credit as Gulf investors reposition their portfolios amid volatility affecting segments of the global lending market. Chief executive Bandr Alhomaly said the Riyadh-based fund has agreed to back India-headquartered venture debt manager Stride Ventures, marking a step in its strategy to widen access to alternative financing for […]

Meta Platforms is redirecting its Horizon Worlds platform towards smartphones, marking a decisive pivot away from its earlier emphasis on Quest virtual reality headsets as the primary gateway to its metaverse ambitions. The company has indicated that development efforts for Horizon Worlds will centre almost entirely on mobile devices, reflecting a broader reassessment of how users access immersive social experiences. Executives have acknowledged that while virtual reality […]

Meta Platforms has struck a landmark long-term agreement with Advanced Micro Devices to buy tens of billions of dollars’ worth of AI processors and data-centre hardware over the next five years, a deal that could exceed $100 billion and reshape the competitive landscape for artificial-intelligence infrastructure. This multiyear pact will see Meta deploy up to six gigawatts of AMD-based computing capacity, starting with initial shipments in the second […]

Etihad Airways posted a near 50 per cent rise in net profit to $698 million for 2025, as expanded capacity and firm travel demand across key markets pushed passenger numbers higher and lifted seat occupancy. The Abu Dhabi carrier said its performance reflected stronger yields, disciplined cost management and a broader network, with chief executive Antonoaldo Neves pointing to sustained investment in product upgrades and customer satisfaction. […]

  • UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk
  • In a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeks
  • UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies.

GUANGDONG, CHINA & BAGSVÆRD, DENMARK – Media OutReach Newswire – 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).

UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.

The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo in Chinese people with overweight or obesity. From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed for people treated with UBT251 was 19.7% (-17.5 kg) compared to 2.0% (-1.6kg) in the placebo group after 24 weeks of treatment[i].

Moreover, all dose groups of UBT251 showed statistically significant improvements relative to placebo on key secondary endpoints, including waist circumference, blood glucose, blood pressure and lipids.

In the trial, UBT251 appeared to have a safe and well-tolerated profile. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with incretin-based therapies.

“The success of the phase 2 clinical trial of UBT251 in China represents another significant milestone in TUL’s innovation-driven development,” said Mr Tsoi Hoi Shan, Chairman of TUL. “We will continue to focus on chronic diseases, including endocrine and metabolic disorders, accelerate the further development of UBT251, and strive to bring more high-quality treatment options to patients worldwide at the earliest opportunity.”

“We are very encouraged by these data from the trial in China, which demonstrate the potential of UBT251 and its differentiated clinical profile and safety and tolerability profile,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “We look forward to reporting data from a global trial with UBT251 conducted by Novo Nordisk next year.”

Novo Nordisk recently initiated a global phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk also expects to initiate a phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.

United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate a phase 3 trial in Chinese patients with overweight or obesity.

About the Chinese phase 2 trial

This randomized, double-blind, placebo-controlled trial enrolled a total of 205 Chinese patients with obesity (BMI ≥ 28.0 kg/m²) or overweight (24.0 kg/m² ≤ BMI < 28.0 kg/m²) with at least one weight-related comorbidity. The baseline mean body weight of the patients was 92.2 kg, with a baseline mean BMI of 33.1 kg/m².

Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg, or placebo for 24 weeks.

The primary endpoint of the trial was the percentage change in body weight from baseline after 24 weeks of treatment.

About UBT251

UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.

In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.


[i] Based on the efficacy estimand according to the trial protocol, regardless of dose modification

Hashtag: #UBT251

The issuer is solely responsible for the content of this announcement.

About TUL and United Biotechnology

Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China. TUL currently boasts seven production bases, covering intermediate products, bulk medicine, finished products, veterinary drugs, empty capsule casings, and medical devices, with the sales networks dotted across nearly 80 countries and regions. United Biotechnology, located in the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, serves as the biopharmaceutical R&D headquarter of TUL. United Biotechnology focuses on the development of high-end biopharmaceuticals to treat major chronic diseases. For more information, please visit .

About Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. For more information, visit , , , , and .

Advertisements

Krafton has appointed a new chief artificial intelligence officer as the South Korean games publisher accelerates efforts to embed advanced AI systems across its development studios and flagship franchises, including PUBG. The company confirmed that it has brought in a senior AI specialist with experience spanning large language models, machine learning infrastructure and applied gaming technologies to lead what it described as the next phase of its […]

Kyndryl has unveiled a Cyber Defense Operations Center in Bengaluru, bringing its network and security operations under a single command structure as enterprises confront an escalation in AI-enabled cyber attacks. The new facility, described by the company as a Cyber Defense Operations Center, is designed to integrate traditional network monitoring with advanced threat detection, incident response and resilience planning. Executives said the unified model is intended to […]

Renault is set to take full control of Flexis, the electric van joint venture it formed with Volvo Group and CMA CGM, marking a decisive shift in the French carmaker’s strategy to consolidate its position in the fast-growing light commercial vehicle segment. The company confirmed it will buy out the stakes held by truckmaker Volvo and shipping group CMA CGM in the venture, which was launched to […]

Arabian Post Staff -Dubai Dubai Electricity and Water Authority has opened discussions with a visiting United States delegation to expand cooperation in sustainable power, hydrogen and advanced energy technologies, underscoring Dubai’s ambition to position itself at the forefront of the global energy transition. Saeed Mohammed Al Tayer, Managing Director and Chief Executive of DEWA, held talks in Dubai with Robert Hertzberg, senior fellow at Mission Possible Partnership […]

Michael Saylor has indicated that his company could expand its already vast Bitcoin holdings, renewing debate over corporate exposure to the world’s largest cryptocurrency and reinforcing his long-standing conviction that digital assets will define what he calls the “Orange Century”. Saylor, executive chairman of MicroStrategy, now rebranded as Strategy, shared remarks on social media that were widely interpreted by market participants as a signal of further purchases. […]

Aston Martin is exploring the sale of branding rights linked to its Formula One team as the luxury carmaker warns that losses are set to deepen, underscoring the financial strain facing one of Britain’s most storied automotive marques. The company said it is assessing options to monetise the commercial value of the Aston Martin name within Formula One, a move that could involve selling or licensing branding […]

Starbucks Corp’s India venture is accelerating store openings and introducing new menu innovations, including protein foam coffee, as it deepens its bet on the world’s most populous country even while losses widen. Tata Starbucks Pvt., the 50:50 joint venture between Starbucks Corporation and Tata Group, plans to prioritise scale over short-term profitability, according to chief executive Sushant Dash. The strategy underscores a long-term view of India as […]

Arabian Post Staff -Dubai Former title holders are set to cross paths at the Dubai Duty Free Tennis Championships after the official draw for the ATP 500 event produced a string of high-profile match-ups that promise a week of elite competition at the Dubai Duty Free Tennis Stadium. The men’s tournament, one of the most established stops on the ATP Tour’s Middle East swing, has again attracted […]

Arabian Post Staff -Dubai President Donald Trump has declared an immediate increase of the global tariff rate to 15 per cent, intensifying a high-stakes confrontation over trade policy following a ruling by the United States Supreme Court that he exceeded his authority with earlier broad tariff measures. The move comes as he invoked a different legal framework to maintain pressure on foreign producers and to limit what […]

Japan’s SBI Holdings has announced plans to issue a ¥10 billion onchain bond that will be settled via blockchain technology and offer XRP rewards to eligible retail investors, marking one of the most prominent efforts by a major financial group to merge traditional fixed-income products with digital asset incentives. The offering, branded as SBI START Bonds, will provide a fixed interest rate and use distributed ledger infrastructure […]

Arabian Post Staff -Dubai A strategic partnership signed in Riyadh this week is aimed at transforming veterinary vaccine production in Saudi Arabia through domestic manufacturing and advanced technology transfers, marking a decisive shift in the Kingdom’s approach to animal health and biosecurity. Under the patronage of Abdulrahman bin Abdulmohsen Al-Fadhli, Minister of Environment, Water and Agriculture and chairman of the National Livestock and Fisheries Development Program, Saudi […]

Markets fluctuated sharply on Friday as digital assets and traditional financial instruments digested the U. S. Supreme Court’s decision that struck down former President Donald Trump’s sweeping tariff regime, triggering a brief rally in bitcoin followed by rapid sell-offs and mixed sentiment among investors. The ruling, handed down by a 6-3 majority, found that the use of the International Emergency Economic Powers Act to impose broad tariffs […]

Mayo Clinic Platform is positioning the Gulf as a proving ground for a new generation of data-driven healthcare, with its chief operating officer Maneesh Goyal outlining plans to expand the organisation’s digital ecosystem and deploy two flagship offerings, Orchestrate and Insights, across the region. Speaking on the sidelines of World Health Expo Dubai 2026, Goyal said the future of medicine will be shaped less by individual hospitals […]

Saudi Arabia’s state-owned artificial intelligence company Humain has committed $3 billion to Elon Musk’s AI venture xAI as part of a substantial funding round conducted just before the startup was brought under the umbrella of his space technology firm SpaceX. The deal immediately positioned Humain as a significant minority shareholder, with its equity in xAI converted into SpaceX shares after the acquisition, the company said. The transaction […]

Arabian Post Staff -Dubai   Saudi Arabian Oil Co, known globally as Saudi Aramco, is forecast to post a net profit of 91.9 billion Saudi riyals in the fourth quarter of 2025, marking a 5.9 per cent increase compared to the same period a year earlier but a 5.5 per cent decline from the third quarter, according to earnings estimates by AlJazira Capital. The projections reflect the […]

By T N Ashok At the center of Bharat Mandapam, the chiselled, lotus-shaped convention complex that has become the theatre for India’s global ambitions, Prime Minister Narendra Modi stood for a “family photo” that looked less like a diplomatic formality and more like a merger of Silicon Valley and the Westphalian order. To his left […]

The article India Positions Itself As The AI World’s Third Pole Under PM Modi’s Active Leadership appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

  AD Ports Group has increased its global network to 36 ports and terminals with the addition of Aqaba Multipurpose Port in Jordan, marking another step in the Abu Dhabi-based operator’s overseas expansion strategy. Ahmed Al Mutawa, Regional Chief Executive Officer of AD Ports Group, said the company’s footprint now stretches across the Middle East, Central Asia, Africa and Europe, covering the UAE, Jordan, Kazakhstan, Pakistan, Spain, […]

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA